肺癌精准治疗的影像学:当前技术水平
本文综述精准治疗时代肺癌影像学进展,聚焦非小细胞肺癌精准治疗对影像的影响、分子与基因组生物标志物及影像解读陷阱,以及纵向肿瘤动力学、放射组学和分子功能成像等精准影像方法。旨在帮助放射科医生跟进肺癌治疗进展并作为多学科团队关键成员。
要点
- 精准治疗已成为肺癌当前标准治疗,放射科医生需了解其影像学意义。
- 影像解读需注意分子与基因组生物标志物相关的陷阱。
- 纵向肿瘤动力学、放射组学和分子功能成像是精准影像的发展方向。
核心结论
- 精准治疗是肺癌当前标准治疗,放射科医生需掌握其影像学表现并作为多学科团队关键成员参与诊疗。
研究设计与样本
- 本文为综述,检索范围与纳入文献原文未报告。
临床应用与阅片要点
- 放射科医生应了解非小细胞肺癌精准治疗进展及其对影像的影响,以保持知识更新。
- 影像解读时需注意分子与基因组生物标志物相关的陷阱。
- 可关注纵向肿瘤动力学、放射组学及分子与功能成像等精准影像方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Advances in characterization of molecular and genomic abnormalities specific to lung cancer have made precision therapy the current standard of care for lung cancer treatment. This article will provide a cutting-edge review of imaging of lung cancer in the current era of precision medicine. The focus of the article includes (a) an update on the recent advances in precision therapy for non-small cell lung cancer and their implications on imaging; (b) molecular and genomic biomarkers and pitfalls of image interpretations for lung cancer precision therapy; and (c) review of the current approaches and future directions of precision imaging for lung cancer, emphasizing emerging observations in longitudinal tumor kinetics, radiomics, and molecular and functional imaging. The article is designed to help radiologists to remain up to date in the rapidly evolving world of lung cancer therapy and serve as key members of multidisciplinary teams caring for these patients.
引用
- Park H, Sholl LM, Hatabu H, et al. Imaging of Precision Therapy for Lung Cancer: Current State of the Art. Radiology. 2019. PMID: 31385753. doi:10.1148/radiol.2019190173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。